National Blood Authority Board

Established under the National Blood Authority Act 2003, the National Blood Authority (NBA) Board provides advice to the General Manager about the performance of the NBA's functions.  The Board is not a decision making body and has no formal or direct role in the governance or management of the NBA.  The Board does however, consider key strategic issues facing the NBA.

The NBA Board’s roles and responsibilities fall into three main categories:

  • Providing strategic direction;
  • Helping to ensure effective governance, including the provision of advice on fraud, audit and risk management and the monitoring of the NBA’s financial reporting; and
  • Liaising with stakeholders to strengthen relationships, promote the role of the NBA and contribute to the development of the organisation in a manner that furthers stakeholders’ requirements.

Membership

The Board is appointed by the Australian Government Minister for Health for a four-year term, based on nominees selected by the  Council of Australian Governments (COAG) Health Council (former Standing Council on Health (SCoH)). The Board is required to consist of:

  • A Chair;
  • A person representing the interests of the Commonwealth;
  • 1 or 2 persons representing the interests of the States and Territories;
  • A person representing the community
  • A person with expertise in public health issues relating to human blood; and
  • A person with financial or commercial expertise.

Further information is available from the NBA Board Secretariat by email (board [at] blood.gov.au) or by telephone (02 6151 5066).

Current Board Members

Ms Gayle Ginnane - Chair

Ms Gayle Ginnane was CEO of the Private Health Insurance Administration Council, a government agency reporting to the Minister for Health and Ageing, with financial and regulatory responsibility for the private health insurance industry until May 2008 and has broad experience as a senior manager in an insurance and regulatory environment, and an in depth understanding of governance, risk management and finance.

Ms Ginnane has considerable experience as an independent director on a number of boards, both commercial and not for profit, in the voluntary, government and private sectors. As well as Chair of the NBA Board, Ms Ginnane is a councillor on the Australian Pharmacy Council and a director of Police Health. She has also contributed to a number of voluntary organisations at senior and Board levels including Scouts ACT, the Arthur Shakespeare Foundation for Scouting and the Community Living Project.

Ms Ginnane is a member of the Institute of Public Administration, a fellow of the Australian Institute of Company Directors and an affiliate member of the Institute of Actuaries of Australia.

Ms Ginnane was appointed Chair of the NBA Board in January 2017.

Adjunct Professor Chris Brook – State/Territory representative (large jurisdiction)

Professor Chris Brook is an independent health policy consultant.

He has held the position of Chief Advisor Innovation, Safety and Quality for the Department of Health and Human Services (DHHS), Victoria, a flexible that relates to in depth analysis and thinking about major policy issues, separate from day-to-day operations. Examples include Clinical Trials, Quality and Safety, Innovation and Transformation approaches to improve services to all Victorians.

As a personal appointment, he has also held the position of State Health and Medical Commander (Emergency Management). This position provides command and coordination across the whole of DHHS services, encompassing all hospitals; ambulances; and others when a large scale emergency event occurs.

He sits on the Clinical Trials Advisory Committee auspiced by the Commonwealth Department of Industry; and sits on the Advisory Board of the National Blood Authority, the Advisory Board of the Australian Commission on Safety and Quality in Health Care and the Board of the Centre for Evidence in Intervention and Preventive Science. He Chairs the Advisory Board of the Deakin School of Medicine.

Professor Brook was appointed to the NBA Board in January 2017.

Professor Lyn Beazley - State/Territory representative (small jurisdiction)

After graduating from Oxford and Edinburgh Universities, Lyn Beazley built an internationally renowned research team in Neuroscience that focused on recovery from brain damage, much of her investigations undertaken as Winthrop Professor at The University of Western Australia. Currently she is Sir Walter Murdoch Distinguished Professor of Science at Murdoch University.

Lyn was honoured to be Chief Scientist of Western Australia from 2006 to 2013, advising the WA Government on science, innovation and technology as well as acting as an Ambassador for science locally, nationally and internationally. With extensive experience serving on advisory bodies, Lyn currently serves several boards including the Federal Government’s Bionic Vision Australia and the WA State Government’s Technology and Industry Advisory Council. Lyn was a Trustee of the Western Australian Museum from 1999-2006 and currently is Patron of the Friends of the Museum. Recently Lyn joined the Board of the Western Australian Art Gallery Foundation.

In 2009 Professor Beazley was awarded Officer of the Order of Australia and elected a Fellow of the Australian Academy of Technological Sciences and Engineering later that year.  In 2011 she was inducted into the inaugural Western Australian Women’s Hall of Fame, followed by being elected a Fellow of the Australian College of Educators and a Companion of Engineers Australia. Lyn has worked to promote Science, Technology, Engineering and Mathematics to the community, especially to young people, and in 2012 Lyn became the second recipient of the Governor’s Award for Giving, in recognition of her enthusiastic philanthropy. In 2015 Lyn was accorded the honour of being inducted into the Western Australian Science Hall of Fame and in November was thrilled and honoured to be announced as WA Australian of the Year for 2015. Lyn was appointed to the NBA Board in January 2017.

Mr Mark Cormack – Australian Government representative

Mr Mark Cormack is responsible for strategic national health policy, portfolio strategies and international engagement at the Department of Health. His National Programme responsibilities include Primary Health, Mental Health, Public Hospital Funding agreements and dental.

Prior to joining the department in February 2015 Mark was Deputy Secretary of the Immigration Status Resolution Group (ISRG) in the Department of Immigration and Border Protection (DIBP) from August 2013 – January 2015. ISRG is responsible for managing and resolving the immigration status of people who do not have legal authority to be in Australia or who are in breach of their visa conditions. The group is also responsible for the onshore detention network, community detention, bridging visa programmes, and the department’s compliance and removals functions. In addition, the group works with other countries to implement offshore processing and refugee settlement. Mark was the Department’s senior executive responsible for implementation of Operation Sovereign Borders.

Prior to joining DIBP, Mark was appointed the first Chief Executive Officer of Health Workforce Australia (HWA) in January 2010. HWA was a Commonwealth Statutory Authority, established by the Council of Australian Governments (COAG) which planned, funded, researched and delivered programmes to enhance and develop Australia’s health workforce.

From July 2006 to January 2010 Mark was Chief Executive of ACT Health.

Mark has had a number of senior roles in the public healthcare system, including Member, Australian Health Ministers’ Advisory Council (AHMAC); Chair, AHMAC Health Policy Priorities Principal Committee; and Board director, National E Health Transition Authority.

Mark has worked in and for the public healthcare sector for over 30 years in various capacities as a health professional, senior manager, policy maker, planner, agency head and industry advocate. He has a Bachelor of Applied Science (University of Sydney) and Master of Health Management (University of Wollongong).

He was appointed to the NBA Board in January 2017.

Mr Paul Bedbrook – Financial expert

Mr Paul Bedbrook has had a connection with blood issues via his personal involvement with haemophilia for over two decades. He is the father of two adult sons with haemophilia. For much of those two decades Mr Bedbrook has been involved with the Haemophilia Foundation NSW (HFNSW) and the Haemophilia Foundation Australia (HFA). He is a past President of HFNSW and past Treasurer of HFA. He brings his personal experiences with blood issues to the Board as well as feedback from a community of individuals who rely on the blood and plasma products distributed to Australia's health services under the auspices of the NBA.

Professionally, Mr Bedbrook has over 30 years of experience in financial services. He was a senior executive for over 20 years with the Dutch global banking, insurance and investment group, ING. His early career was as an investment analyst and investment portfolio manager and he was the General Manager Investments and Chief Investment Officer for the Mercantile Mutual (ING) Group in Sydney from 1987 to 1995. In the decade to 2010, he was President and CEO, INGDIRECT, Canada; CEO and director of ING Australia and Regional CEO, ING Asia Pacific based in Hong Kong. His current roles include: Chairman of Zurich Financial Services Australia Ltd, Independent non-executive Director of Credit Union Australia (CUA) Ltd, Independent Chairman of ASX listed Elanor Investors Group and Chairman of Disability Sports Australia.

Mr Bedbrook was appointed community representative on the NBA Board from May 2011 to August 2013. Mr Bedbrook was appointed financial expert on the NBA Board in August 2013 and is a member of the NBA Audit Committee.

Associate Professor Alison Street – Public health expert

Alison graduated in 1971 from Monash University with first class honours in medicine. After completing postgraduate training in clinical and laboratory haematology in Melbourne and Sydney she spent three years in clinical research in Boston USA. She returned to Melbourne to work with Monash University and Alfred Health in 1984 and retired from positions of Head of Laboratory Haematology and Haemostasis-Thrombosis (including Haemophilia) in 2012. Her main professional interests were in haemostasis-thrombosis, transfusion medicine and teaching. During her tenure at Alfred Health, Alison was president of the Haematology Society of Australia and New Zealand (1996-8) and chief examiner in haematology for the Royal College of Pathologists of Australasia (2001-6).

She was a board member with the Blood Service (ARCBS) from 1998-2004 and World Federation of Hemophilia (WFH) from 2002-12 (Vice-President Medical 2008-12).

Alison's present appointments are: Clinical Adjunct Associate Professor in the Department of Immunology and Pathology, Monash University; Member of the ARCBS Advisory Committee; Chair of the ARCBS Research Advisory Committee; Chair of the NBA Haemovigilance Advisory Committee; Consultant to the Department of Health for clinical haematology; and Member of the steering committee for the Asia-Pacific Haemophilia Working Group.

Alison received the award of Officer in the Order of Australia in 2006 for services to haematology and the community of people with congenital bleeding disorders. She is an honorary life member of the Haematology Society of Australia and New Zealand, Australian Society of Thrombosis and Haemostasis and the Australian and New Zealand Society of Blood Transfusion. She was appointed to the NBA Board in January 2017.

Ms Patricia Warn – Community representative

Trained originally as a secondary school teacher in Tasmania, Ms Warn was a social and political researcher for the ABC's Four Corners programme in Sydney for several years before becoming a Ministerial Advisor in Canberra across social security, health, community services and immigration. She organised national community consultations to inform policy development in reforming disability services, women's health, HIV/AIDS, Creutzfeldt–Jakob disease awareness and aged care.

Ms Warn was a member of the Commonwealth Immigration Review Tribunal for five years.

In retirement Ms Warn was appointed to the NSW Ministerial Advisory Committee on Ageing and became an Official Visitor to mental health facilities under the NSW Mental Health Act. She served for seven years as a Board member of Uniting Care Ageing's Sydney region and remains on its Advisory Council.

Ms Warn has been a lay member of the NSW Law Society's Professional Conduct Committee for a decade and has represented consumer interests on committees of the Australian Commission on Safety and Quality in Health Care, Health Workforce Australia, the Australian Council on Health Care Standards and the Australian Health Practitioner Registration Agency. She is on the Board of the Aged Rights Service (TARS) in Sydney.

Ms Warn's personal commitment to the NBA stems from her mother's life being saved by blood transfusions following a postpartum haemorrhage 60 years ago.

Ms Warn was appointed to the NBA Board as the community representative in August 2013.